Next Article in Journal
Tsv-N1: A Novel DNA Algal Virus that Infects Tetraselmis striata
Next Article in Special Issue
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
Previous Article in Journal
Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine
Previous Article in Special Issue
Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems

Bone Marrow Gene Therapy for HIV/AIDS

Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands
Author to whom correspondence should be addressed.
Academic Editor: Eric O. Freed
Viruses 2015, 7(7), 3910-3936;
Received: 11 May 2015 / Revised: 9 July 2015 / Accepted: 13 July 2015 / Published: 17 July 2015
(This article belongs to the Special Issue Gene Technology and Resistance to Viruses - Reviews)
Bone marrow gene therapy remains an attractive option for treating chronic immunological diseases, including acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV). This technology combines the differentiation and expansion capacity of hematopoietic stem cells (HSCs) with long-term expression of therapeutic transgenes using integrating vectors. In this review we summarize the potential of bone marrow gene therapy for the treatment of HIV/AIDS. A broad range of antiviral strategies are discussed, with a particular focus on RNA-based therapies. The idea is to develop a durable gene therapy that lasts the life span of the infected individual, thus contrasting with daily drug regimens to suppress the virus. Different approaches have been proposed to target either the virus or cellular genes encoding co-factors that support virus replication. Some of these therapies have been tested in clinical trials, providing proof of principle that gene therapy is a safe option for treating HIV/AIDS. In this review several topics are discussed, ranging from the selection of the antiviral molecule and the viral target to the optimal vector system for gene delivery and the setup of appropriate preclinical test systems. The molecular mechanisms used to formulate a cure for HIV infection are described, including the latest antiviral strategies and their therapeutic applications. Finally, a potent combination of anti-HIV genes based on our own research program is described. View Full-Text
Keywords: bone marrow; hematopoietic stem cell (HSC); virus; antiviral; gene therapy; lentiviral vector; HIV-1; RNAi bone marrow; hematopoietic stem cell (HSC); virus; antiviral; gene therapy; lentiviral vector; HIV-1; RNAi
Show Figures

Figure 1

MDPI and ACS Style

Herrera-Carrillo, E.; Berkhout, B. Bone Marrow Gene Therapy for HIV/AIDS. Viruses 2015, 7, 3910-3936.

AMA Style

Herrera-Carrillo E, Berkhout B. Bone Marrow Gene Therapy for HIV/AIDS. Viruses. 2015; 7(7):3910-3936.

Chicago/Turabian Style

Herrera-Carrillo, Elena, and Ben Berkhout. 2015. "Bone Marrow Gene Therapy for HIV/AIDS" Viruses 7, no. 7: 3910-3936.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop